Global and United States Cancer Immunotherapies Market Insights, Forecast to 2027

Global and United States Cancer Immunotherapies Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Cancer Immunotherapies Product Introduction
1.2 Market by Type
1.2.1 Global Cancer Immunotherapies Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Vaccines
1.2.4 Immunomodulators
1.2.5 Adoptive Cell transfer
1.2.6 Checkpoint Inhibitors
1.3 Market by Application
1.3.1 Global Cancer Immunotherapies Market Size Growth Rate by Application
1.3.2 Breast Cancer
1.3.3 Leukemia
1.3.4 Lymphoma
1.3.5 Melanoma
1.3.6 Colorectal Cancer
1.3.7 Non-Small Cell Lung Cancer
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cancer Immunotherapies Market Size, Estimates and Forecasts
2.1.1 Global Cancer Immunotherapies Revenue 2016-2027
2.1.2 Global Cancer Immunotherapies Sales 2016-2027
2.2 Global Cancer Immunotherapies, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Cancer Immunotherapies Historical Market Size by Region (2016-2021)
2.3.1 Global Cancer Immunotherapies Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Cancer Immunotherapies Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Cancer Immunotherapies Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Cancer Immunotherapies Sales Forecast by Region (2022-2027)
2.4.2 Global Cancer Immunotherapies Revenue Forecast by Region (2022-2027)
3 Global Cancer Immunotherapies Competitor Landscape by Players
3.1 Global Top Cancer Immunotherapies Manufacturers by Sales
3.1.1 Global Cancer Immunotherapies Sales by Manufacturer (2016-2021)
3.1.2 Global Cancer Immunotherapies Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Cancer Immunotherapies Manufacturers by Revenue
3.2.1 Key Cancer Immunotherapies Manufacturers Covered: Ranking by Revenue
3.2.2 Global Cancer Immunotherapies Revenue by Manufacturers (2016-2021)
3.2.3 Global Cancer Immunotherapies Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Cancer Immunotherapies Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Cancer Immunotherapies Revenue in 2020
3.2.6 Global Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Cancer Immunotherapies Price by Manufacturers
3.4 Global Cancer Immunotherapies Manufacturing Base Distribution, Product Types
3.4.1 Cancer Immunotherapies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Cancer Immunotherapies Product Type
3.4.3 Date of International Manufacturers Enter into Cancer Immunotherapies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Cancer Immunotherapies Market Size by Type (2016-2021)
4.1.1 Global Cancer Immunotherapies Sales by Type (2016-2021)
4.1.2 Global Cancer Immunotherapies Revenue by Type (2016-2021)
4.1.3 Cancer Immunotherapies Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Cancer Immunotherapies Market Size Forecast by Type (2022-2027)
4.2.1 Global Cancer Immunotherapies Sales Forecast by Type (2022-2027)
4.2.2 Global Cancer Immunotherapies Revenue Forecast by Type (2022-2027)
4.2.3 Cancer Immunotherapies Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Cancer Immunotherapies Market Size by Application (2016-2021)
5.1.1 Global Cancer Immunotherapies Sales by Application (2016-2021)
5.1.2 Global Cancer Immunotherapies Revenue by Application (2016-2021)
5.1.3 Cancer Immunotherapies Price by Application (2016-2021)
5.2 Cancer Immunotherapies Market Size Forecast by Application (2022-2027)
5.2.1 Global Cancer Immunotherapies Sales Forecast by Application (2022-2027)
5.2.2 Global Cancer Immunotherapies Revenue Forecast by Application (2022-2027)
5.2.3 Global Cancer Immunotherapies Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Cancer Immunotherapies Market Size YoY Growth 2016-2027
6.1.1 United States Cancer Immunotherapies Sales YoY Growth 2016-2027
6.1.2 United States Cancer Immunotherapies Revenue YoY Growth 2016-2027
6.1.3 United States Cancer Immunotherapies Market Share in Global Market 2016-2027
6.2 United States Cancer Immunotherapies Market Size by Players (International and Local Players)
6.2.1 United States Top Cancer Immunotherapies Players by Sales (2016-2021)
6.2.2 United States Top Cancer Immunotherapies Players by Revenue (2016-2021)
6.3 United States Cancer Immunotherapies Historic Market Review by Type (2016-2021)
6.3.1 United States Cancer Immunotherapies Sales Market Share by Type (2016-2021)
6.3.2 United States Cancer Immunotherapies Revenue Market Share by Type (2016-2021)
6.3.3 United States Cancer Immunotherapies Price by Type (2016-2021)
6.4 United States Cancer Immunotherapies Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Cancer Immunotherapies Sales Forecast by Type (2022-2027)
6.4.2 United States Cancer Immunotherapies Revenue Forecast by Type (2022-2027)
6.4.3 United States Cancer Immunotherapies Price Forecast by Type (2022-2027)
6.5 United States Cancer Immunotherapies Historic Market Review by Application (2016-2021)
6.5.1 United States Cancer Immunotherapies Sales Market Share by Application (2016-2021)
6.5.2 United States Cancer Immunotherapies Revenue Market Share by Application (2016-2021)
6.5.3 United States Cancer Immunotherapies Price by Application (2016-2021)
6.6 United States Cancer Immunotherapies Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Cancer Immunotherapies Sales Forecast by Application (2022-2027)
6.6.2 United States Cancer Immunotherapies Revenue Forecast by Application (2022-2027)
6.6.3 United States Cancer Immunotherapies Price Forecast by Application (2022-2027)
7 North America
7.1 North America Cancer Immunotherapies Market Size YoY Growth 2016-2027
7.2 North America Cancer Immunotherapies Market Facts & Figures by Country
7.2.1 North America Cancer Immunotherapies Sales by Country (2016-2021)
7.2.2 North America Cancer Immunotherapies Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Cancer Immunotherapies Market Size YoY Growth 2016-2027
8.2 Asia Pacific Cancer Immunotherapies Market Facts & Figures by Region
8.2.1 Asia Pacific Cancer Immunotherapies Sales by Region (2016-2021)
8.2.2 Asia Pacific Cancer Immunotherapies Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Cancer Immunotherapies Market Size YoY Growth 2016-2027
9.2 Europe Cancer Immunotherapies Market Facts & Figures by Country
9.2.1 Europe Cancer Immunotherapies Sales by Country (2016-2021)
9.2.2 Europe Cancer Immunotherapies Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Cancer Immunotherapies Market Size YoY Growth 2016-2027
10.2 Latin America Cancer Immunotherapies Market Facts & Figures by Country
10.2.1 Latin America Cancer Immunotherapies Sales by Country (2016-2021)
10.2.2 Latin America Cancer Immunotherapies Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Cancer Immunotherapies Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Cancer Immunotherapies Market Facts & Figures by Country
11.2.1 Middle East and Africa Cancer Immunotherapies Sales by Country (2016-2021)
11.2.2 Middle East and Africa Cancer Immunotherapies Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Description and Business Overview
12.1.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Cancer Immunotherapies Products Offered
12.1.5 Amgen Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Cancer Immunotherapies Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Roche Cancer Immunotherapies Products Offered
12.3.5 Roche Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Corporation Information
12.4.2 Bristol-Myers Squibb Description and Business Overview
12.4.3 Bristol-Myers Squibb Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bristol-Myers Squibb Cancer Immunotherapies Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Bayer
12.5.1 Bayer Corporation Information
12.5.2 Bayer Description and Business Overview
12.5.3 Bayer Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Bayer Cancer Immunotherapies Products Offered
12.5.5 Bayer Recent Development
12.6 Merck
12.6.1 Merck Corporation Information
12.6.2 Merck Description and Business Overview
12.6.3 Merck Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Merck Cancer Immunotherapies Products Offered
12.6.5 Merck Recent Development
12.7 ARMO BioSciences (Eli Lilly)
12.7.1 ARMO BioSciences (Eli Lilly) Corporation Information
12.7.2 ARMO BioSciences (Eli Lilly) Description and Business Overview
12.7.3 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.7.4 ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Products Offered
12.7.5 ARMO BioSciences (Eli Lilly) Recent Development
12.8 Novartis
12.8.1 Novartis Corporation Information
12.8.2 Novartis Description and Business Overview
12.8.3 Novartis Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis Cancer Immunotherapies Products Offered
12.8.5 Novartis Recent Development
12.9 Pfizer
12.9.1 Pfizer Corporation Information
12.9.2 Pfizer Description and Business Overview
12.9.3 Pfizer Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Cancer Immunotherapies Products Offered
12.9.5 Pfizer Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Corporation Information
12.10.2 Johnson & Johnson Description and Business Overview
12.10.3 Johnson & Johnson Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Johnson & Johnson Cancer Immunotherapies Products Offered
12.10.5 Johnson & Johnson Recent Development
12.11 Amgen
12.11.1 Amgen Corporation Information
12.11.2 Amgen Description and Business Overview
12.11.3 Amgen Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Amgen Cancer Immunotherapies Products Offered
12.11.5 Amgen Recent Development
12.12 Gilead Sciences
12.12.1 Gilead Sciences Corporation Information
12.12.2 Gilead Sciences Description and Business Overview
12.12.3 Gilead Sciences Cancer Immunotherapies Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Gilead Sciences Products Offered
12.12.5 Gilead Sciences Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Cancer Immunotherapies Industry Trends
13.2 Cancer Immunotherapies Market Drivers
13.3 Cancer Immunotherapies Market Challenges
13.4 Cancer Immunotherapies Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Cancer Immunotherapies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Cancer Immunotherapies Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Monoclonal Antibodies (MABs)
Table 3. Major Manufacturers of Cancer Vaccines
Table 4. Major Manufacturers of Immunomodulators
Table 5. Major Manufacturers of Adoptive Cell transfer
Table 6. Major Manufacturers of Checkpoint Inhibitors
Table 7. Global Cancer Immunotherapies Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 8. Global Cancer Immunotherapies Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 9. Global Cancer Immunotherapies Sales by Regions (2016-2021) & (K Units)
Table 10. Global Cancer Immunotherapies Sales Market Share by Regions (2016-2021)
Table 11. Global Cancer Immunotherapies Revenue by Regions (2016-2021) & (US$ Million)
Table 12. Global Cancer Immunotherapies Sales Forecast by Region (2022-2027) & (K Units)
Table 13. Global Cancer Immunotherapies Sales Market Share Forecast by Region (2022-2027)
Table 14. Global Cancer Immunotherapies Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 15. Global Cancer Immunotherapies Revenue Market Share Forecast by Region (2022-2027)
Table 16. Global Cancer Immunotherapies Sales by Manufacturers (2016-2021) (K Units)
Table 17. Global Cancer Immunotherapies Sales Share by Manufacturers (2016-2021)
Table 18. Ranking of Global Top Cancer Immunotherapies Manufacturers by Revenue (US$ Million) in 2020
Table 19. Cancer Immunotherapies Revenue by Manufacturers (2016-2021) (US$ Million)
Table 20. Cancer Immunotherapies Revenue Share by Manufacturers (2016-2021)
Table 21. Global Cancer Immunotherapies Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 22. Global Cancer Immunotherapies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Immunotherapies as of 2020)
Table 23. Key Manufacturers Cancer Immunotherapies Price (2016-2021) (USD/Unit)
Table 24. Cancer Immunotherapies Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Cancer Immunotherapies Product Type
Table 26. Date of International Manufacturers Enter into Cancer Immunotherapies Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Immunotherapies Sales by Type (2016-2021) (K Units)
Table 29. Global Cancer Immunotherapies Sales Share by Type (2016-2021)
Table 30. Global Cancer Immunotherapies Revenue by Type (2016-2021) (US$ Million)
Table 31. Global Cancer Immunotherapies Revenue Share by Type (2016-2021)
Table 32. Cancer Immunotherapies Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 33. Global Cancer Immunotherapies Sales Forecast by Type (2022-2027) & (K Units)
Table 34. Global Cancer Immunotherapies Sales Market Share Forecast by Type (2022-2027)
Table 35. Global Cancer Immunotherapies Revenue Forecast V (2022-2027) & (US$ Million)
Table 36. Global Cancer Immunotherapies Revenue Market Share Forecast by Type (2022-2027)
Table 37. Global Cancer Immunotherapies Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Cancer Immunotherapies Sales by Application (2016-2021) (K Units)
Table 39. Global Cancer Immunotherapies Sales Share by Application (2016-2021)
Table 40. Global Cancer Immunotherapies Revenue by Application (2016-2021) (US$ Million)
Table 41. Global Cancer Immunotherapies Revenue Share by Application (2016-2021)
Table 42. Cancer Immunotherapies Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 43. Global Cancer Immunotherapies Sales Forecast by Application (2022-2027) & (K Units)
Table 44. Global Cancer Immunotherapies Sales Market Share Forecast by Application (2022-2027)
Table 45. Global Cancer Immunotherapies Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 46. Global Cancer Immunotherapies Revenue Market Share Forecast by Application (2022-2027)
Table 47. Global Cancer Immunotherapies Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 48. United States Cancer Immunotherapies Sales (K Units) of Key Companies (2016-2021)
Table 49. United States Cancer Immunotherapies Sales Share by Company (2016-2021)
Table 50. United States Cancer Immunotherapies Revenue (US$ Million) by Company (2016-2021)
Table 51. United States Cancer Immunotherapies Revenue Share by Company (2016-2021)
Table 52. United States Cancer Immunotherapies Sales (K Units) by Type (2016-2021)
Table 53. United States Cancer Immunotherapies Sales Share by Type (2016-2021)
Table 54. United States Cancer Immunotherapies Revenue (US$ Million) Market Share by Type (2016-2021)
Table 55. United States Cancer Immunotherapies Price (USD/Unit) by Type (2016-2021)
Table 56. United States Cancer Immunotherapies Sales (K Units) by Type (2022-2027)
Table 57. United States Cancer Immunotherapies Sales Share by Type (2022-2027)
Table 58. United States Cancer Immunotherapies Revenue (US$ Million) Market Share by Type (2022-2027)
Table 59. United States Cancer Immunotherapies Revenue Share by Type (2022-2027)
Table 60. United States Cancer Immunotherapies Price (USD/Unit) by Type (2022-2027)
Table 61. United States Cancer Immunotherapies Sales (K Units) by Application (2016-2021)
Table 62. United States Cancer Immunotherapies Sales Share by Application (2016-2021)
Table 63. United States Cancer Immunotherapies Revenue (US$ Million) Market Share by Application (2016-2021)
Table 64. United States Cancer Immunotherapies Price (USD/Unit) by Application (2016-2021)
Table 65. United States Cancer Immunotherapies Sales (K Units) by Application (2022-2027)
Table 66. United States Cancer Immunotherapies Sales Share by Application (2022-2027)
Table 67. United States Cancer Immunotherapies Revenue (US$ Million) Market Share by Application (2022-2027)
Table 68. United States Cancer Immunotherapies Revenue Share by Application (2022-2027)
Table 69. United States Cancer Immunotherapies Price (USD/Unit) by Application (2022-2027)
Table 70. North America Cancer Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 71. North America Cancer Immunotherapies Sales Market Share by Country (2016-2021)
Table 72. North America Cancer Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 73. North America Cancer Immunotherapies Revenue Market Share by Country (2016-2021)
Table 74. Asia Pacific Cancer Immunotherapies Sales by Region (2016-2021) & (K Units)
Table 75. Asia Pacific Cancer Immunotherapies Sales Market Share by Region (2016-2021)
Table 76. Asia Pacific Cancer Immunotherapies Revenue by Region (2016-2021) & (US$ Million)
Table 77. Asia Pacific Cancer Immunotherapies Revenue Market Share by Region (2016-2021)
Table 78. Europe Cancer Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 79. Europe Cancer Immunotherapies Sales Market Share by Country (2016-2021)
Table 80. Europe Cancer Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 81. Europe Cancer Immunotherapies Revenue Market Share by Country (2016-2021)
Table 82. Latin America Cancer Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 83. Latin America Cancer Immunotherapies Sales Market Share by Country (2016-2021)
Table 84. Latin Americaa Cancer Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 85. Latin America Cancer Immunotherapies Revenue Market Share by Country (2016-2021)
Table 86. Middle East and Africa Cancer Immunotherapies Sales by Country (2016-2021) & (K Units)
Table 87. Middle East and Africa Cancer Immunotherapies Sales Market Share by Country (2016-2021)
Table 88. Middle East and Africa Cancer Immunotherapies Revenue by Country (2016-2021) & (US$ Million)
Table 89. Middle East and Africa Cancer Immunotherapies Revenue Market Share by Country (2016-2021)
Table 90. Amgen Corporation Information
Table 91. Amgen Description and Business Overview
Table 92. Amgen Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 93. Amgen Cancer Immunotherapies Product
Table 94. Amgen Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 98. AstraZeneca Product
Table 99. AstraZeneca Recent Development
Table 100. Roche Corporation Information
Table 101. Roche Description and Business Overview
Table 102. Roche Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 103. Roche Product
Table 104. Roche Recent Development
Table 105. Bristol-Myers Squibb Corporation Information
Table 106. Bristol-Myers Squibb Description and Business Overview
Table 107. Bristol-Myers Squibb Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 108. Bristol-Myers Squibb Product
Table 109. Bristol-Myers Squibb Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Description and Business Overview
Table 112. Bayer Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Bayer Product
Table 114. Bayer Recent Development
Table 115. Merck Corporation Information
Table 116. Merck Description and Business Overview
Table 117. Merck Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Merck Product
Table 119. Merck Recent Development
Table 120. ARMO BioSciences (Eli Lilly) Corporation Information
Table 121. ARMO BioSciences (Eli Lilly) Description and Business Overview
Table 122. ARMO BioSciences (Eli Lilly) Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. ARMO BioSciences (Eli Lilly) Product
Table 124. ARMO BioSciences (Eli Lilly) Recent Development
Table 125. Novartis Corporation Information
Table 126. Novartis Description and Business Overview
Table 127. Novartis Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. Novartis Product
Table 129. Novartis Recent Development
Table 130. Pfizer Corporation Information
Table 131. Pfizer Description and Business Overview
Table 132. Pfizer Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Pfizer Product
Table 134. Pfizer Recent Development
Table 135. Johnson & Johnson Corporation Information
Table 136. Johnson & Johnson Description and Business Overview
Table 137. Johnson & Johnson Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Johnson & Johnson Product
Table 139. Johnson & Johnson Recent Development
Table 140. AbbVie Corporation Information
Table 141. AbbVie Description and Business Overview
Table 142. AbbVie Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. AbbVie Product
Table 144. AbbVie Recent Development
Table 145. Gilead Sciences Corporation Information
Table 146. Gilead Sciences Description and Business Overview
Table 147. Gilead Sciences Cancer Immunotherapies Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 148. Gilead Sciences Product
Table 149. Gilead Sciences Recent Development
Table 150. Cancer Immunotherapies Market Trends
Table 151. Cancer Immunotherapies Market Drivers
Table 152. Cancer Immunotherapies Market Challenges
Table 153. Cancer Immunotherapies Market Restraints
Table 154. Cancer Immunotherapies Customers List
Table 155. Cancer Immunotherapies Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Immunotherapies Product Picture
Figure 2. Global Cancer Immunotherapies Sales Market Share by Type in 2020 & 2027
Figure 3. Monoclonal Antibodies (MABs) Product Picture
Figure 4. Cancer Vaccines Product Picture
Figure 5. Immunomodulators Product Picture
Figure 6. Adoptive Cell transfer Product Picture
Figure 7. Checkpoint Inhibitors Product Picture
Figure 8. Global Cancer Immunotherapies Sales Market Share by Application in 2020 & 2027
Figure 9. Breast Cancer
Figure 10. Leukemia
Figure 11. Lymphoma
Figure 12. Melanoma
Figure 13. Colorectal Cancer
Figure 14. Non-Small Cell Lung Cancer
Figure 15. Cancer Immunotherapies Report Years Considered
Figure 16. Global Cancer Immunotherapies Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Cancer Immunotherapies Market Size 2016-2027 (US$ Million)
Figure 18. Global Cancer Immunotherapies Sales 2016-2027 (K Units)
Figure 19. Global Cancer Immunotherapies Market Size Market Share by Region: 2021 Versus 2027
Figure 20. Global Cancer Immunotherapies Sales Market Share by Region (2016-2021)
Figure 21. Global Cancer Immunotherapies Sales Market Share by Region in 2020
Figure 22. Global Cancer Immunotherapies Revenue Market Share by Region (2016-2021)
Figure 23. Global Cancer Immunotherapies Revenue Market Share by Region in 2020
Figure 24. Global Cancer Immunotherapies Sales Share by Manufacturer in 2020
Figure 25. The Top 10 and 5 Players Market Share by Cancer Immunotherapies Revenue in 2020
Figure 26. Cancer Immunotherapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 27. Global Cancer Immunotherapies Sales Market Share by Type (2016-2021)
Figure 28. Global Cancer Immunotherapies Sales Market Share by Type in 2020
Figure 29. Global Cancer Immunotherapies Revenue Market Share by Type (2016-2021)
Figure 30. Global Cancer Immunotherapies Revenue Market Share by Type in 2020
Figure 31. Global Cancer Immunotherapies Sales Market Share by Application (2016-2021)
Figure 32. Global Cancer Immunotherapies Sales Market Share by Application in 2020
Figure 33. Global Cancer Immunotherapies Revenue Market Share by Application (2016-2021)
Figure 34. Global Cancer Immunotherapies Revenue Market Share by Application in 2020
Figure 35. United States Cancer Immunotherapies Sales Growth Rate 2016-2027 (K Units)
Figure 36. United States Cancer Immunotherapies Revenue Growth Rate 2016-2027 (US$ Million)
Figure 37. United States Cancer Immunotherapies Market Share in Global Market 2016-2027
Figure 38. United States 5 and 10 Largest Cancer Immunotherapies Players Market Share by Revenue in Cancer Immunotherapies in 2020
Figure 39. United States Cancer Immunotherapies Revenue Share by Type (2016-2021)
Figure 40. United States Cancer Immunotherapies Revenue Growth Rate by Type in 2016 & 2020
Figure 41. United States Cancer Immunotherapies Revenue Share by Application (2016-2021)
Figure 42. United States Cancer Immunotherapies Revenue Growth Rate by Application in 2016 & 2020
Figure 43. North America Cancer Immunotherapies Sales Growth Rate 2016-2021 (K Units)
Figure 44. North America Cancer Immunotherapies Revenue Growth Rate 2016-2021 (US$ Million)
Figure 45. North America Cancer Immunotherapies Sales Market Share by Country in 2020
Figure 46. North America Cancer Immunotherapies Revenue Market Share by Country in 2020
Figure 47. U.S. Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 48. U.S. Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Canada Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 50. Canada Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. Europe Cancer Immunotherapies Sales Growth Rate 2016-2021 (K Units)
Figure 52. Europe Cancer Immunotherapies Revenue Growth Rate 2016-2021 (US$ Million)
Figure 53. Europe Cancer Immunotherapies Sales Market Share by Country in 2020
Figure 54. Europe Cancer Immunotherapies Revenue Market Share by Country in 2020
Figure 55. Germany Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 56. Germany Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. France Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 58. France Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. U.K. Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 60. U.K. Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Italy Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 62. Italy Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Russia Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 64. Russia Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Asia Pacific Cancer Immunotherapies Sales Growth Rate 2016-2021 (K Units)
Figure 66. Asia Pacific Cancer Immunotherapies Revenue Growth Rate 2016-2021 (US$ Million)
Figure 67. Asia Pacific Cancer Immunotherapies Sales Market Share by Region in 2020
Figure 68. Asia Pacific Cancer Immunotherapies Revenue Market Share by Region in 2020
Figure 69. China Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 70. China Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Japan Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 72. Japan Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. South Korea Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 74. South Korea Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. India Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)
Figure 76. India Cancer Immunotherapies Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Australia Cancer Immunotherapies Sales Growth Rate (2016-2021) (K Units)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Cancer Immunomodulator Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......

Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......

Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......

Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125

According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......

Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024

Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......

Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101

Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......

T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......

Global Kaposi Sarcoma Market Status and Outlook 2023-2028

Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107

Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......

Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs